PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22240665-5	2012	Rosiglitazone and T0901317 induced ABCA1 and ABCG1 several-fold, but LPS reduced only ABCG1.	Rosiglitazone	0-13	ATP binding cassette subfamily G member 1	Mus musculus	45-50	
29908181-8	2018	PPARgamma activation via rosiglitazone also prevents the MWCNT-induced deficiency of PPARgamma-regulated ATP-binding cassette lipid transporter-G1 (ABCG1) expression.	Rosiglitazone	25-38	ATP binding cassette subfamily G member 1	Mus musculus	105-146	
29908181-8	2018	PPARgamma activation via rosiglitazone also prevents the MWCNT-induced deficiency of PPARgamma-regulated ATP-binding cassette lipid transporter-G1 (ABCG1) expression.	Rosiglitazone	25-38	ATP binding cassette subfamily G member 1	Mus musculus	148-153	
29908181-11	2018	Our results indicate that restoration of homeostatic ABCG1 levels by rosiglitazone correlates with both reduced pulmonary lipid accumulation, and decreased alveolar macrophage activation.	Rosiglitazone	69-82	ATP binding cassette subfamily G member 1	Mus musculus	53-58	
27807703-9	2017	PPARgamma activation by rosiglitazone rescued LXRalpha and ABCG1 expression and reduced TLR4-induced inflammation and lipid accumulation.	Rosiglitazone	24-37	ATP binding cassette subfamily G member 1	Mus musculus	59-64